Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Orthopedics
Volume 2013, Article ID 473014, 5 pages
http://dx.doi.org/10.1155/2013/473014
Case Report

The Massive Bleeding after the Operation of Hip Joint Surgery with the Acquired Haemorrhagic Coagulation Factor XIII(13) Deficiency: Two Case Reports

1Department of Orthopaedic Surgery, Juntendo Shizuoka Hospital, Izunagaoka 1129, Izunokuni, Shizuoka 410-2295, Japan
2Department of Orthopaedic Surgery, Juntendo University, Hongou 3-1-3, Bunkyo Tokyo 113-8431, Japan

Received 12 January 2013; Accepted 11 February 2013

Academic Editors: M. G. Lykissas, A. Nehme, S. A. Papadakis, and S. Parekh

Copyright © 2013 Akio Kanda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ichinose, “Hemorrhagic acquired factor XIII(13) deficiency and acquired hemorrhaphilia 13 revisited,” Seminars in Thrombosis and Hemostasis, vol. 37, no. 4, pp. 382–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Abdalla, H. Lother, A. Langer, Y. El Faramawy, and U. Quitterer, “Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis,” Cell, vol. 119, no. 3, pp. 343–354, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Kasahara, M. Souri, M. Kaneda, T. Miki, N. Yamamoto, and A. Ichinose, “Impaired clot retraction in factor XIII A subunit-deficient mice,” Blood, vol. 115, no. 6, pp. 1277–1279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Jennings, S. Kitchen, T. A. Woods, and F. E. Preston, “Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study,” Journal of Thrombosis and Haemostasis, vol. 1, no. 12, pp. 2603–2608, 2003. View at Google Scholar · View at Scopus
  5. R. Gerlach, A. Raabe, M. Zimmermann, A. Siegemund, and V. Seifert, “Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures,” Surgical Neurology, vol. 54, no. 3, pp. 260–266, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. W. F. Korte, “XIII in perioperative coagulation management,” Best Practice and Research, vol. 24, no. 1, pp. 85–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ichinose, “Extracellular transglutaminase: factor XIII,” Progress in Experimental Tumor Research, vol. 38, pp. 192–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Ichinose, T. Asahina, and T. Kobayashi, “Congenital blood coagulation factor XIII deficiency and perinatal management,” Current Drug Targets, vol. 6, no. 5, pp. 541–549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Loland, “Acquired inhibitors of fibrin stabilization: a class of hemorrhagic disorders of diverse origins,” in Anticoagulants: Physiologic, Physiolosic, Pathologic & Pharmacologic, D. Green, Ed., pp. 169–191, CRC Press, Boca Raton, Fla, USA, 1994. View at Google Scholar
  10. J. S. C. Caudill, W. L. Nichols, E. A. Plumhoff et al., “Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma,” Transfusion, vol. 49, no. 4, pp. 765–770, 2009. View at Publisher · View at Google Scholar · View at Scopus